Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol.

Kuhn KP, Byrne DW, Arbogast PG, Doyle TP, Loyd JE, Robbins IM
Am J Respir Crit Care Med. 2003 167 (4): 580-6

PMID: 12446266 · DOI:10.1164/rccm.200204-333OC

MeSH Terms (19)

Adolescent Adult Aged Age of Onset Antihypertensive Agents Child Epoprostenol Female Hemodynamics Humans Hypertension, Pulmonary Male Middle Aged Proportional Hazards Models Retrospective Studies Statistics, Nonparametric Survival Analysis Tennessee Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: